Sign In
Buy STOK
Stoke Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -4.60. In total, the insiders bought 1.27M and sold 141.12K STOK shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-4.60 |
| ● Buy | 1.27M shares |
| ● Sell | 141.12K shares |
|
50% Buy Activity
Strong Positive Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jun 16, 2026 Sell |
Allan Jonathan General Counsel & Corp Sec |
1 457 Value: $43.6K |
||
|
Jun 03, 2026 Buy |
Kaye Edward M. Md Director |
17 786 Value: $524.0K |
||
|
Jun 03, 2026 Buy |
Harrison Seth Loring Director |
17 786 Value: $524.0K |
||
|
Jun 03, 2026 Buy |
Burstein Jennifer Director |
17 786 Value: $524.0K |
||
|
Jun 03, 2026 Buy |
Levin Arthur A Director |
17 786 Value: $524.0K |
||
|
Jun 03, 2026 Buy |
Smith Julie Director |
17 786 Value: $524.0K |
||
|
Jun 03, 2026 Buy |
Tzianabos Arthur Director |
17 786 Value: $524.0K |
||
|
Jun 03, 2026 Buy |
Krainer Adrian R. Director |
17 786 Value: $524.0K |
||
|
Jun 01, 2026 Sell |
Ticho Barry Chief Medical Officer |
1 795 Value: $54.9K |
||
|
May 01, 2026 Sell |
Ticho Barry Chief Medical Officer |
2 243 Value: $73.5K |
||
|
Apr 03, 2026 Buy |
Kahn Clare Director |
30 782 Value: $1.01M |
||
|
Apr 03, 2026 Buy |
Kahn Clare Insider |
0 Value: $0 |
||
|
Apr 01, 2026 Sell |
Ticho Barry Chief Medical Officer |
1 838 Value: $60.0K |
||
|
Mar 20, 2026 Sell |
Allan Jonathan General Counsel & Corp Sec |
601 Value: $20.7K |
||
|
Mar 20, 2026 Sell |
Allan Jonathan General Counsel & Corp Sec |
8 692 Value: $292.4K |
||
|
Mar 19, 2026 Buy |
Ticho Barry Chief Medical Officer |
1 365 Value: $3K |
||
|
Mar 19, 2026 Sell |
Ticho Barry Chief Medical Officer |
1 461 Value: $43.8K |
||
|
Mar 19, 2026 Buy |
Ticho Barry Chief Medical Officer |
1 365 Value: $3K |
||
|
Mar 18, 2026 Sell |
Allan Jonathan General Counsel & Corp Sec |
334 Value: $10.6K |
||
|
Mar 18, 2026 Sell |
Hoitt Jason Chief Patient Officer |
30 Value: $986 |
||
|
Mar 18, 2026 Sell |
Hoitt Jason Chief Patient Officer |
1 762 Value: $55.1K |
||
|
Mar 18, 2026 Sell |
Hoitt Jason Chief Patient Officer |
139 Value: $4K |
||
|
Mar 18, 2026 Sell |
Allan Jonathan General Counsel & Corp Sec |
72 Value: $2K |
||
|
Mar 18, 2026 Sell |
Allan Jonathan General Counsel & Corp Sec |
4 222 Value: $132.1K |
||
|
Mar 18, 2026 Sell |
Ticho Barry Chief Medical Officer |
103 Value: $3K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
